Skip to content

    Research Use Only

    This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.

    🔬 100K+ researchers trust BodyHackGuide — Join r/BodyHackGuide

    CJC-1295 No-DAC (Mod GRF 1-29)

    GH SecretagoguePreclinical / Research peptide

    Also known as: Mod GRF 1-29, CJC-1295 without DAC, Modified GRF 1-29, CJC No-DAC

    CJC-1295 No-DAC (also known as Mod GRF 1-29) is a 29-amino-acid synthetic peptide modeled on the active N-terminal fragment of human Growth Hormone Releasing Hormone (GHRH 1-29). Four amino acid substitutions stabilize the peptide against enzymatic degradation but, unlike CJC-1295 with DAC, this version does NOT carry the Drug Affinity Complex (DAC) - meaning it has a short serum half-life (~30 minutes) and produces a single physiological GH pulse rather than sustained GHRH stimulation. The short pulse profile is closer to natural pulsatile GHRH biology, which makes Mod GRF 1-29 the preferred choice when researchers want to amplify natural GH peaks (e.g., paired with ipamorelin pre-bed) without continuous GHRH receptor stimulation..

    Half-Life: ~30 minutes (no DAC means no extended binding)Route: Subcutaneous
    Last reviewed:
    GH Secretagogue
    Category
    Preclinical / Research peptide
    Research Stage

    Overview

    At A Glance

    Mechanism

    Binds the GHRH receptor on anterior pituitary somatotrophs, triggering Gs-coupled cAMP signaling and pulsatile growth hormone release. Without DAC, the peptide clears within ~30 minutes, producing a single GH pulse and returning the GHRH receptor to baseline sensitivity. This con

    Half-Life
    ~30 minutes (no DAC means no extended binding)
    Dosing
    Subcutaneous 2-3x per day (typical: AM, post-workout, pre-bed)
    Dose Range
    100 mcg per dose, 2-3x dailymcg
    Routes
    Subcutaneous
    Common Vials
    2mgmg5mgmg
    Potential Benefits
    Single GH pulse mimicking natural GHRH biologySynergistic with GHRP peptides (3-5x GH release)No DAC = no receptor desensitizationPre-bed dosing supports deep sleep and recoveryImproved body composition over 8-12 week cycles
    Safety Notes
    Common
    Injection site irritationTransient flushing post-injectionMild headache during first 1-2 weeksMild water retention with long use
    Serious
    Carpal tunnel-like symptoms (rare, dose-related)Hyperinsulinemia with chronic high-dose useNo long-term human safety data

    Overview

    CJC-1295 No-DAC (also known as Mod GRF 1-29) is a 29-amino-acid synthetic peptide modeled on the active N-terminal fragment of human Growth Hormone Releasing Hormone (GHRH 1-29). Four amino acid substitutions stabilize the peptide against enzymatic degradation but, unlike CJC-1295 with DAC, this version does NOT carry the Drug Affinity Complex (DAC) - meaning it has a short serum half-life (~30 minutes) and produces a single physiological GH pulse rather than sustained GHRH stimulation. The short pulse profile is closer to natural pulsatile GHRH biology, which makes Mod GRF 1-29 the preferred choice when researchers want to amplify natural GH peaks (e.g., paired with ipamorelin pre-bed) without continuous GHRH receptor stimulation.

    Potential Research Fields

    Growth hormone biologyGHRH receptorPituitary somatotrophsSleep architectureRecovery

    Chemical Information

    IUPAC Name

    Not yet available

    CAS Number

    Not yet available

    Molecular Formula

    Not yet available

    Molecular Mass

    Not yet available

    Amino Acid Sequence

    Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg (modified)

    Dosing & Protocols

    Unlock Dosing Protocols

    Free account gets you:

    • View beginner, intermediate & advanced protocols
    • See weight-based dosing calculations
    • Access cycle length & frequency data

    2,800+ researchers already in

    Research

    Unlock Research Data

    Free account gets you:

    • Browse PubMed study summaries
    • See clinical trial phases & results
    • Access mechanism of action details

    2,800+ researchers already in

    Interactions

    Contraindications

    Active malignancy. Pregnancy and breastfeeding. Active diabetic retinopathy. Active acromegaly or pituitary adenoma. Caution in T2D - GH antagonizes insulin action.

    Research Disclaimer

    This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.

    No listings found for CJC-1295 No-DAC (Mod GRF 1-29).

    Get CJC-1295 No-DAC (Mod GRF 1-29) Price Drop Alerts

    Set a target price and we'll notify you when any vendor drops below it.

    Sign in to leave a review

    Reviews on BodyHackGuide are tied to verified user accounts and moderated before publishing. Sign in (free, no spam) to share your experience with CJC-1295 No-DAC (Mod GRF 1-29).

    Research Score

    45

    0 PubMed studies

    Quality Indicators

    Data Completeness

    50%
    Description
    Mechanism of Action
    Chemical Data
    Dosing Protocols
    Safety Profile
    PubMed Studies
    Interactions
    Vendor Listings

    Quick Facts

    Half-Life

    ~30 minutes (no DAC means no extended binding)

    Administration

    Subcutaneous

    Trial Phase

    Preclinical / Research peptide

    Safety Profile

    Common Side Effects

    • Injection site irritation
    • Transient flushing post-injection
    • Mild headache during first 1-2 weeks
    • Mild water retention with long use

    Research Disclaimer

    This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.

    Frequently Asked Questions

    What is CJC-1295 No-DAC (Mod GRF 1-29) used for in research?

    CJC-1295 No-DAC (also known as Mod GRF 1-29) is a 29-amino-acid synthetic peptide modeled on the active N-terminal fragment of human Growth Hormone Releasing Hormone (GHRH 1-29). Four amino acid substitutions stabilize the peptide against enzymatic degradation but, unlike CJC-1295 with DAC, this version does NOT carry the Drug Affinity Complex (DAC) - meaning it has a short serum half-life (~30 minutes) and produces a single physiological GH pulse rather than sustained GHRH stimulation.

    The short pulse profile is closer to natural pulsatile GHRH biology, which makes Mod GRF 1-29 the preferred choice when researchers want to amplify natural GH peaks (e.g., paired with ipamorelin pre-bed) without continuous GHRH receptor stimulation.

    What forms does CJC-1295 No-DAC (Mod GRF 1-29) come in?

    CJC-1295 No-DAC (Mod GRF 1-29) is available in vials, capsules, and sprays forms.

    How much does CJC-1295 No-DAC (Mod GRF 1-29) cost?

    Pricing varies by vendor and form.

    How do I compare CJC-1295 No-DAC (Mod GRF 1-29) vendors?

    Compare prices, payment methods, shipping, and COA scores across 0 vendors.

    Research Tools

    Related Compounds

    View All

    Free 2026 Peptide Cheat Sheet — 50 pages, PDF

    Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.

    Download Free

    Need bloodwork before starting?

    Full hormone + metabolic panels from Anabolic Insights. Code CHONCH for first-order discount.

    ResearchChemHQ BPC-157 500mcg × 60 capsules bottle
    IN STOCK · COA PER BATCH

    BPC-157 Caps

    60 caps × 500mcg. HPLC + COA on every batch, ≥99% purity. Same molecule as the vials, just oral so it travels. code REDDIT stacks with their 5-vial 20% off and 10-vial 40% off tiers.

    COUPON CODEREDDIT
    Grab a bottle →
    Research use only. Not for human consumption.|BodyHackGuide promotes vendors. We do not sell these products.